Literature DB >> 12911843

C-reactive protein and risk of cardiovascular disease: evidence and clinical application.

Paul M Ridker1, Shari S Bassuk, Peter P Toth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12911843     DOI： 10.1007/s11883-003-0004-3

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  68 in total

1.  Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

Authors:  M A Albert; E Danielson; N Rifai; P M Ridker
Journal:  JAMA       Date:  2001-07-04       Impact factor: 56.272

2.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

3.  C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis.

Authors:  T P Zwaka; V Hombach; J Torzewski
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

4.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial.

Authors:  Katherine Esposito; Alessandro Pontillo; Carmen Di Palo; Giovanni Giugliano; Mariangela Masella; Raffaele Marfella; Dario Giugliano
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

5.  C-reactive protein and myocardial infarction.

Authors:  Pamela Sakkinen; Robert D Abbott; J David Curb; Beatriz L Rodriguez; Katsuhiko Yano; Russell P Tracy
Journal:  J Clin Epidemiol       Date:  2002-05       Impact factor: 6.437

6.  Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies.

Authors:  Allen P Burke; Russell P Tracy; Frank Kolodgie; Gray T Malcom; Arthur Zieske; Robert Kutys; Joseph Pestaner; John Smialek; Renu Virmani
Journal:  Circulation       Date:  2002-04-30       Impact factor: 29.690

7.  Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.

Authors:  Subodh Verma; Shu-Hong Li; Mitesh V Badiwala; Richard D Weisel; Paul W M Fedak; Ren-Ke Li; Bikramjit Dhillon; Donald A G Mickle
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

8.  Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

Authors:  C J Packard; D S O'Reilly; M J Caslake; A D McMahon; I Ford; J Cooney; C H Macphee; K E Suckling; M Krishna; F E Wilkinson; A Rumley; G D Lowe
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

Review 9.  C-reactive protein and other inflammatory risk markers in acute coronary syndromes.

Authors:  Gavin J Blake; Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

10.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690
View more
  18 in total

1.  Exposure to polycyclic aromatic hydrocarbons and serum inflammatory markers of cardiovascular disease.

Authors:  John D Clark; Berrin Serdar; David J Lee; Kristopher Arheart; James D Wilkinson; Lora E Fleming
Journal:  Environ Res       Date:  2012-05-22       Impact factor: 6.498

Review 2.  High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone.

Authors:  Andreas Pfützner; Thomas Schöndorf; Markolf Hanefeld; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

3.  Sarcopenic obesity and inflammation in the InCHIANTI study.

Authors:  Matthew A Schrager; E Jeffrey Metter; Eleanor Simonsick; Alessandro Ble; Stefania Bandinelli; Fulvio Lauretani; Luigi Ferrucci
Journal:  J Appl Physiol (1985)       Date:  2006-11-09

4.  Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.

Authors:  Kenneth J Colley; Robert L Wolfert; Michael E Cobble
Journal:  EPMA J       Date:  2011-03-10       Impact factor: 6.543

Review 5.  Low-density lipoprotein reduction in high-risk patients: how low do you go?

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

6.  Usefulness of C-reactive protein as a marker for prediction of future coronary events in the asian Indian population: Indian atherosclerosis research study.

Authors:  Veena S Rao; Natesha B Kadarinarasimhiah; Shibu John; Sridhara Hebbagodi; Jayashree Shanker; Vijay V Kakkar
Journal:  Int J Vasc Med       Date:  2010-06-28

7.  Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study).

Authors:  Marcus E Kleber; Tanja B Grammer; Wilfried Renner; Winfried März
Journal:  BMC Med Genet       Date:  2010-11-09       Impact factor: 2.103

8.  The serum high-sensitive C reactive protein and homocysteine levels to evaluate the prognosis of acute ischemic stroke.

Authors:  Tahir Yoldas; Murat Gonen; Ahmet Godekmerdan; Fulya Ilhan; Ednan Bayram
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

9.  Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.

Authors:  Richard L Dunbar; Stephen J Nicholls; Kevin C Maki; Eli M Roth; David G Orloff; Danielle Curcio; Judith Johnson; Douglas Kling; Michael H Davidson
Journal:  Lipids Health Dis       Date:  2015-09-02       Impact factor: 3.876

Review 10.  Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on Sirtuins.

Authors:  Graziamaria Corbi; Andrea Bianco; Viviana Turchiarelli; Michele Cellurale; Federica Fatica; Aurora Daniele; Gennaro Mazzarella; Nicola Ferrara
Journal:  Int J Mol Sci       Date:  2013-06-17       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.